Terumo Cardiovascular Systems Corp - Strategic SWOT Analysis Review

December 2020 | 25 pages | ID: TD968263027EN
GlobalData

Abstracts

Terumo Cardiovascular Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Terumo Cardiovascular Systems Corp (TCSC), a subsidiary of Terumo Corporation, is a provider of medical equipment and devices for cardiac and vascular surgeries. The company’s major products include autotransfusion products, beating heart and surgery stabilization products, cannulae, endoscopic products, monitoring systems, perfusion products, platelet therapy, sternotomy products and vascular grafts. Its products find application in various procedures such as from aortic aneurysm repair to surgeries for peripheral artery disease and coronary artery bypass grafting to valve replacements and heart transplants. The company distributes products across North America, Europe, Asia, the Middle East, Africa, South and Central America. TCSC is headquartered in Ann Arbor, Michigan, the US.

Terumo Cardiovascular Systems Corp Key Recent Developments

Aug 24,2020: Terumo Cardiovascular and CytoSorbents collaborate to commercialize cytoSorb in ten U.S. Hotspot States under Emergency Use Authorization for COVID-19

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

Table of Contents
List of Tables
List of Figures

SECTION 1 - ABOUT THE COMPANY

Terumo Cardiovascular Systems Corp - Key Facts
Terumo Cardiovascular Systems Corp - Key Employees
Terumo Cardiovascular Systems Corp - Key Employee Biographies
Terumo Cardiovascular Systems Corp - Major Products and Services
Terumo Cardiovascular Systems Corp - History
Terumo Cardiovascular Systems Corp - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Company Overview
Terumo Cardiovascular Systems Corp - Business Description
Terumo Cardiovascular Systems Corp - SWOT Analysis
SWOT Analysis - Overview
Terumo Cardiovascular Systems Corp - Strengths
Terumo Cardiovascular Systems Corp - Weaknesses
Terumo Cardiovascular Systems Corp - Opportunities
Terumo Cardiovascular Systems Corp - Threats
Terumo Cardiovascular Systems Corp - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Terumo Cardiovascular Systems Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Terumo Cardiovascular Systems Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
Terumo Cardiovascular Systems Corp, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Aug 24, 2020: Terumo Cardiovascular and CytoSorbents collaborate to commercialize cytoSorb in ten U.S. Hotspot States under Emergency Use Authorization for COVID-19

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Terumo Cardiovascular Systems Corp, Key Facts
Terumo Cardiovascular Systems Corp, Key Employees
Terumo Cardiovascular Systems Corp, Key Employee Biographies
Terumo Cardiovascular Systems Corp, Major Products and Services
Terumo Cardiovascular Systems Corp, History
Terumo Cardiovascular Systems Corp, Key Competitors
Terumo Cardiovascular Systems Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Terumo Cardiovascular Systems Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
Terumo Cardiovascular Systems Corp, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Terumo Cardiovascular Systems Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Terumo Cardiovascular Systems Corp, Medical Equipment, Deals by Type, 2014 to YTD 2020

COMPANIES MENTIONED

Baxter BioSurgery Inc
Cook Medical Inc
Maquet Cardiovascular LLC
TriVascular Inc
Vascular Pathways, Inc.